286-Myeloid-Targeted Immunocytokines

This article details the development and preclinical testing of a novel cancer immunotherapy called MiTEs (myeloid-targeted immunocytokines and natural killer (NK)/T cell enhancers). The researchers engineered MiTEs to overcome the immunosuppressive tumor microenvironment by simultaneously targeting Tumor-Associated Macrophages (TAMs) and activating effector lymphocytes (T and NK cells). Specifica...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动